Wai Man Chan

Title: Innovations by Wai Man Chan

Introduction

Wai Man Chan is a notable inventor based in Shaukeiwan, China. He has made significant contributions to the field of cancer detection through innovative methodologies. With a total of four patents to his name, Chan's work focuses on non-invasive techniques for determining cancer types and methylation profiles.

Latest Patents

Chan's latest patents include groundbreaking systems, methods, and apparatuses for the non-invasive determination of cancer types. These innovations utilize methylation profiles from various tissues and samples. For instance, a methylation profile can be deduced for fetal or tumor tissue by comparing plasma methylation to that of the mother or patient. Additionally, his patents describe how tissue-specific alleles can identify DNA from a fetus or tumor in mixed samples. These profiles can also determine copy number variations in the genome of a fetus or tumor. Furthermore, methylation markers for a fetus have been identified through various techniques, and the methylation level can indicate the level of cancer present.

Career Highlights

Wai Man Chan is affiliated with The Chinese University of Hong Kong, where he continues to advance research in cancer detection technologies. His work has garnered attention for its potential to revolutionize non-invasive cancer diagnostics.

Collaborations

Some of Chan's notable coworkers include Yuk-Ming Dennis Lo and Rossa Wai Kwun Chiu, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Wai Man Chan's innovative work in cancer detection exemplifies the potential of non-invasive methodologies in medical diagnostics. His contributions are paving the way for advancements in the understanding and treatment of cancer.